1Gantz I, Konda Y, Yang YK, et al. Molecular cloning of a novel receptor (cmklrl) with homology to the chemotactic factor receptors [J]. Cytogenet Cell Genet, 1996, 74(4): 286-290.
2Nagpal S, Patel S, Jacobe H, et al. Tazarotene-indueed gene 2 (rig2), a novel retinoid-responsive gene in skin [J]. J Invest Dermatol, 1997, 109(1): 91-95.
3Samson M, Edinger AL, Stordeur P, et al. Chemr23, a putative ehemoattractant receptor, is expressed in monocyte-derived dendritic cells and maerophages and is a coreceptor for siv and some primary hiv-1 strains [J]. Eur J Immunol, 1998, 28(5): 1689-1700.
4Wittamer V, Franssen JD, Vulcano M, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids [J]. J Exp Med, 2003, 198(7): 977-985.
5Goralski KB, McCarthy TC, Hanniman EA, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism [J]. J Biol Chem, 2007, 282 (38): 28175-28188.
6Wittamer V, Bondue B, Guillabert A, et al. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity [J]. J Immunol, 2005, 175(1) : 487-493.
7Zabel BA, Allen SJ, Kulig P, et al. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades [J]. J Biol Chem, 2005, 280 (41) : 34661-34666.
8Du XY, Zabel BA, Myles T, et al. Regulation of chemerin bioactivity by plasma earboxypeptidase n, carboxypeptidase b (activated thrombinactivable fibrinolysis inhibitor), and platelets [J]. J Biol Chem, 2009, 284(2): 751-758.
9Bozaoglu K, Bolton K, McMillan J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome [J]. Endocrinology, 2007, 148(10): 4687-4694.
10Zhang R, Liu S, Guo B, et al. Chemerin induces insulin resistance in rat cardiomyocytes in part through the ERK1/2 signaling pathway[J]. Pharmacology, 2014, 94 ( 5-6): 259-264.
二级参考文献113
1DU X Y, ZABEL B A, MYLES T, et al. Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets[J]. J Biol Chem, 2009,284:751--758.
2WITTAMER V, BONDUE B, GUILLABERT A, et al. Neutrophil-mediated maturation of chemerin., a link between innate and adaptive immunity[J]. J Immunol, 2005,175 :487 - 493.
3GUAI.ILLO O, GONZALEZ-JUANATEY J R, LAGO F. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspeetives[J].Trends Cardiovasc Med, 2007, 17:275--283.
4LEHRKE M, BECKER A, GREIF M, et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atheroselerosis[J]. Eur J Endocrinol,2009,161: 339 - 344.
5SPIROGLOU S G, KOSTOPOULOS C G, VARA- KIS J N, et al. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis[J].J Atheroscler Thromb, 2010,17: 115--130.
6GORALSKI K B, SINAL C J. Elucidation of chemer in and ehemokine-like receptor-1 function in adipo- cytes by adenoviral mediated shRNA knockdown of gene expression[J].Methods Enzymol, 2009,460 : 289 --312.
7BOZAOGLU K, BOLTON K, MCMILLAN J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome [J].Endocrinology, 2007, 148..4687-4694.
8ERNST M C, SINAI. C J. Chemerin: at the cross roads of inflammation and obesity[J]. Trends Endocrinol Metab,2010,21 ..660-667.
9WANG Z, NAKAYAMA T. Inflammation, a link between obesity and cardiovascular disease[J]. Mediators Inflamm, 2010,53 : 5 - 18.
10BOZAOGLU K, SEGAL D, SHIELDS K A, et al. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population[J]. J Clin Endocrinol Metab, 2009,94 : 3085- 3088.
